Ticker LaunchReverse merger · Completed · OTLC
Oncotelic, Inc.
Reverse merger with Mateon Therapeutics, Inc. (MATN)
Oncotelic, Inc. merged into Mateon Therapeutics, Inc. (MATN), a OTC-quoted oncology biotech (formerly OXiGENE), in a reverse merger that takes the private company public. The deal was announced on Apr 18, 2019 and closed on Apr 22, 2019. The combined company trades as Oncotelic Therapeutics, Inc. (OTLC) on OTC.
Oncotelic Therapeutics is a clinical-stage biopharmaceutical company developing cancer treatments based on TGF-beta RNA therapeutics.
- Status
- Completed
- Private company
- Oncotelic, Inc.
- Public company
- Mateon Therapeutics, Inc. (MATN)
- Public company business before
- OTC-quoted oncology biotech (formerly OXiGENE)
- Announced
- Apr 18, 2019
- Closed
- Apr 22, 2019
- Combined company
- Oncotelic Therapeutics, Inc. (OTLC)
- Exchange
- OTC
- Sector
- Biotech & pharma
More on this deal for subscribers
- Ownership split between private and public holders
- Concurrent financing and investors
- Contingent value rights (CVR)
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Form 8-K (closing) Apr 25, 2019
- Press release (closing)
- Press release (announcement)
- All filings on EDGAR CIK 908259
Other completed reverse mergers
- C3J Therapeutics, Inc.into AmpliPhi Biosciences Corporation · May 10, 2019
- China VTV Ltd. (Hong Kong target)into China VTV Limited · May 8, 2019
- Adynxx, Inc.into Alliqua BioMedical, Inc. · May 3, 2019
- Charlie's Chalk Dust, LLCinto True Drinks Holdings, Inc. · Apr 26, 2019
- Immunic AG (German private company)into Vital Therapies, Inc. · Apr 12, 2019
- Gadsden Growth Properties, Inc.into FC Global Realty Incorporated · Apr 5, 2019